This relevant metabolic dependency of FLT3-ITD+ AML cells on glutaminolysis is targetable with cooperation of FLT3-ITD and glutaminase inhibitors to prolong survival in mice with AML (74). Here, FLT3 is linked to acute myeloid leukemia.